siagoside has been researched along with Age-Related Memory Disorders in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Agnati, LF; Biagini, G; Fuxe, K; Grimaldi, R; Merlo Pich, E; Solfrini, V; Toffano, G; Zoli, M | 1 |
| Emerich, DF; Walsh, TJ | 1 |
2 other study(ies) available for siagoside and Age-Related Memory Disorders
| Article | Year |
|---|---|
Siagoside selectively attenuates morphological and functional striatal impairments induced by transient forebrain ischemia in rats.
Topics: Animals; Apomorphine; Behavior, Animal; Brain; Brain Ischemia; Choice Behavior; Corpus Striatum; Dopamine and cAMP-Regulated Phosphoprotein 32; G(M1) Ganglioside; Germ-Free Life; Hippocampus; Male; Memory Disorders; Nerve Tissue Proteins; Phosphoproteins; Prosencephalon; Rats; Rats, Inbred Strains; Stereotyped Behavior | 1992 |
Ganglioside AGF2 prevents the cognitive impairments and cholinergic cell loss following intraventricular colchicine.
Topics: Animals; Behavior, Animal; Cell Survival; Choline O-Acetyltransferase; Colchicine; G(M1) Ganglioside; Injections, Intraventricular; Locomotion; Male; Memory Disorders; Rats | 1991 |